Challenges for nationwide vaccine delivery in African countries

Songane, Mario

doi:10.1007/s10754-017-9229-5

Cited by 39 publications

(39 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In general comparison of vaccine acceptance levels in our ndings (Table 1), there were higher acceptance levels of hypothetical COVID-19 vaccine in countries such as Chine (91.3% (16); Indonesia (93.3%) (9) and USA (69%) (17). We attribute these differences to low levels of global vaccine clinical trials in African (4), inadequate research facilities and limited funding needed in development of vaccines (18). Financial and knowledge constrains in most African countries, have cause highest mortality rates by infectious diseases (19).…”

Section: Discussionmentioning

confidence: 99%

“…Africa has a high population and a growing economy (21), which would be an advantage for increasing potential market for vaccines however there is a lot of political prejudice and policy setting in uence which may be a factor hindering good health service delivery to the people (18). It is popular that in most African countries political leaders often misuse government resources meant for health service procurements (22).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Echoru¹,

Ajambo²,

Bukenya³

2020

Preprint

View full text Add to dashboard Cite

Background: Many countries have drawn their attention on developing Corona virus disease 2019 vaccine however there is less emphasis on whether this vaccine could be accepted in most of these countries. This study aimed to investigate acceptance and risk perception of COVID-19 vaccine in Uganda. Method: A simplified snowball sampling technique was used to select 1067 respondents of 18-70 years in western Uganda using an online questionnaire from July to September 2020. Vaccine acceptability and risk perception was assessed using odds ratio at 95% confidence interval using R software version 3.6.3. Results: The acceptance rate for vaccination against COVID-19 was (53.6%; 572/1067) with participants in the reference age group 18-20 (OR: 1; 95%CI: NA); males (OR: 2.1; 95%CI: 1.56-2.71; P=0.000); tertiary level of education (OR: 2.8; 95%CI: 1.25-6.11; P=0.009); students (OR: 3.19; 95%CI: 1.98-5.15; P=0.000) and non-salary earners (OR: 2.29; 95%CI: 1.53-3.44; P=0.000) significantly more likely to accept the vaccine. Results also showed that (46.4%; 495/1067) of the respondents were un-likely to accept the vaccine. About (44.6%; 476/1067) of the respondents were likely to accept vaccine clinical trials with participants in the reference age group 18-20 (OR: 1; 95%CI: NA), students (OR: 2.37; 95%CI: 1.49-3.77; P=0.000), marrieds (OR: 1.3; 95%CI: 1.03-1.69; P=0.028), and non-salary (OR: 1.56; 95%CI: 1.05-2.30; P=0.029) significantly more likely to accept clinical trials. There were (46.7%; 500/1067) of the respondents who perceived the vaccine as being risky with males (OR: 3.13; 95%CI: 2.33-4.21; P=0.000); students (OR: 2.59; 95%CI: 1.63-4.13; P=0.000); Civil servants (OR: 1.49; 95%CI: 0.98-2.25; P=0.063); and non-salary earners; (OR: 2.34; 95%CI: 1.57-3.47; P=0.000) who significantly perceived the vaccine as being more risky.Conclusion: The level of vaccine acceptance (53.6%) and risk perception (46.7%) was relatively average in western Uganda. In order to ensure successful vaccination process, the government needs to prioritize vaccine acceptance strategies especially among the risky group in the community.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Echoru¹,

Ajambo²,

Bukenya³

2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Studies suggests that reasons for session interruption differ from country to country and these factors include among others: parent/caregivers’ attitude, logistics, health workers knowledge and availability etc. that are affecting immunization service delivery [ 29 , 30 ].…”

Section: Discussionmentioning

confidence: 99%

Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable diseases indicators in the East and Southern African Countries

Bello¹,

Lebo²,

Shibeshi³

et al. 2021

Pan Afr Med J

View full text Add to dashboard Cite

Introduction the coronavirus disease (COVID-19) global pandemic has caused serious disruption to almost all aspect of human endeavor forcing countries to implement unprecedented public health measures aimed at mitigating its effects, such as total lockdown (inter and intra), travel bans, quarantine, social distancing in an effort to contain the spread of the virus. Supportive supervision is a functional component of the immunization systems that allows identification of existing gaps, provides an opportunity for onsite training, and document real-time findings for improvement of the program. The control measures of COVID-19 pandemic have also resulted in limitation of operations of the immunization system including supportive supervision. This has limited many aspects of supportive supervision for surveillance and routine immunization monitoring system in the East and Southern African countries. The aim of this study is to identify the effects of COVID-19 on Integrated Supportive Supervision visits for expanded programme on immunization (EPI) and how it influences the immunization and vaccine preventable disease (VPD) surveillance indicators, and its short-term effect towards notification of increase or decrease morbidity and mortality. Methods we reviewed the integrated supportive supervision (ISS) data and the routine administrative coverage from 19 countries in the East and Southern Africa (ESA) for the period January to August 2019 to analyze the trends in the number of visits, vaccine-preventable diseases (VPD), and routine immunization (RI) indicators using t-test, and compare with the period January to August 2020 during the months of the COVID-19 pandemic. Results thirteen countries out of the 19 considered, had shown a decline in the number of integrated supportive supervision (ISS) visits, with 10 (77%) having more than 59% decrease during the January-August 2020 as compared to the same period 2019. Eleven (57%) of the countries have shown a decrease (p-value < 0.05). Ethiopia and Kenya had the highest drop (p-value < 0.000). Six (32%) had an increase in the number of visits, with Madagascar, Zambia, and Zimbabwe having >100% increase in the number of visits. Sixty-seven percent (67%) of the countries that have decreased in the number of ISS visits have equally witnessed a drop in DPT3 administrative coverage. Countries with a low proportion of outreach sessions conducted in the period of January - August 2020, have all had sessions interruption, with more than 40% of the reasons associated with the lockdown. Conclusion countries have experienced a decrease in the number of supportive supervision visits conducted, during the period of the COVID-19 pandemic and, this has influenced the routine immunization and vaccine-preventable diseases surveillance (VPD) process indicators monitored through the conduct of the visits. Continuous decrease in these performance indicators pose a great threat to the per...

show abstract

“…Any person left behind for whatever reason will not only be in avoidable peril, but will also put the goal of eradication of SARS-Cov-2 at risk [13]. Therefore, the EU and other well-heeled supranational organisations should feel not only morally obliged but also pragmatically well-advised to participate in supplying weaker healthcare systems with sufficient amounts of vaccine and logistic support for their application even in remote areas [14].…”

mentioning

confidence: 99%

Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity

Henn

2020

Vaccine

View full text Add to dashboard Cite

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Commentary Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity

show abstract

Challenges for nationwide vaccine delivery in African countries

Cited by 39 publications

References 63 publications

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda

Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable diseases indicators in the East and Southern African Countries

Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity

Contact Info

Product

Resources

About